Article
p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
Oncogene - 1 Oct 1998
Crook T, Brooks L A, Crossland S, Osin P, Barker K T, Waller J, Philp E, Smith P D, Yulug I, Peto J, Parker G, Allday M J, Crompton M R, Gusterson B A
Abstract excerpt
The status of p53 was investigated in breast tumours arising in germ-line carriers of mutant alleles of BRCA1 and BRCA2 and in a control series of sporadic breast tumours. p53 expression was detected in 20/26 (77%) BRCA1-, 10/22 (45%) BRCA2-associated and 25/72 (35%) grade-matched sporadic tumour...
Topics
- BRCA1 Protein
- BRCA2 Protein
- Breast Neoplasms
- Codon
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- Female
- Gene Expression
- Humans
- Mitosis
- Mutation
- Neoplasm Proteins
- Phenotype
- Transcription Factors